These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15081125)

  • 1. PCR-based detection of the CYP21 deletion and TNXA/TNXB hybrid in the RCCX module.
    Lee HH; Lee YJ; Lin CY
    Genomics; 2004 May; 83(5):944-50. PubMed ID: 15081125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chimeric CYP21P/CYP21 and TNXA/TNXB genes in the RCCX module.
    Lee HH
    Mol Genet Metab; 2005 Jan; 84(1):4-8. PubMed ID: 15639189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An unequal crossover between the RCCX modules of the human MHC leading to the presence of a CYP21B gene and a tenascin TNXB/TNXA-RP2 recombinant between C4A and C4B genes in a patient with juvenile rheumatoid arthritis.
    Rupert KL; Rennebohm RM; Yu CY
    Exp Clin Immunogenet; 1999; 16(2):81-97. PubMed ID: 10343159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diversity of the CYP21P-like gene in CYP21 deficiency.
    Lee HH
    DNA Cell Biol; 2005 Jan; 24(1):1-9. PubMed ID: 15684714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing the Southern blot method and polymerase chain reaction product analysis for chimeric RCCX detection in CYP21A2 deficiency.
    Lee HH; Lee YJ; Chao MC
    Anal Biochem; 2010 Apr; 399(2):293-8. PubMed ID: 19961824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modular variations of the human major histocompatibility complex class III genes for serine/threonine kinase RP, complement component C4, steroid 21-hydroxylase CYP21, and tenascin TNX (the RCCX module). A mechanism for gene deletions and disease associations.
    Yang Z; Mendoza AR; Welch TR; Zipf WB; Yu CY
    J Biol Chem; 1999 Apr; 274(17):12147-56. PubMed ID: 10207042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duplication of 111 bases in exon 1 of the CYP21 gene is combined with deletion of CYP21P-C4B genes in steroid 21-hydroxylase deficiency.
    Lee HH; Chang SF; Lo FS; Chao HT; Lin CY
    Mol Genet Metab; 2003 Jul; 79(3):214-20. PubMed ID: 12855227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the CYP21A2 gene with intergenic recombination and multiple gene deletions in the RCCX module.
    Chang SF; Lee HH
    Genet Test Mol Biomarkers; 2011; 15(1-2):35-42. PubMed ID: 21117955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The chimeric CYP21P/CYP21 gene and 21-hydroxylase deficiency.
    Lee HH
    J Hum Genet; 2004; 49(2):65-72. PubMed ID: 14730433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudogene
    Lao Q; Zhou K; Parker M; Faucz FR; Merke DP
    Genes (Basel); 2023 Jan; 14(2):. PubMed ID: 36833192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An unequal crossover event in RCCX modules of the human MHC resulting in the formation of a TNXB/TNXA hybrid and deletion of the CYP21A.
    Jaatinen T; Chung EK; Ruuskanen O; Lokki ML
    Hum Immunol; 2002 Aug; 63(8):683-9. PubMed ID: 12121677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salt-wasting congenital adrenal hyperplasia phenotype as a result of the TNXA/TNXB chimera 1 (CAH-X CH-1) and the pathogenic IVS2-13A/C > G in CYP21A2 gene.
    Fanis P; Skordis N; Phylactou LA; Neocleous V
    Hormones (Athens); 2023 Mar; 22(1):71-77. PubMed ID: 36264454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ehlers-Danlos Syndrome: Molecular and Clinical Characterization of TNXA/TNXB Chimeras in Congenital Adrenal Hyperplasia.
    Marino R; Garrido NP; Ramirez P; Notaristéfano G; Moresco A; Touzon MS; Vaiani E; Finkielstain G; Obregón MG; Balbi V; Soria I; Belgorosky A
    J Clin Endocrinol Metab; 2021 Jun; 106(7):e2789-e2802. PubMed ID: 33482002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Prevalence of the Chimeric TNXA/TNXB Gene and Clinical Symptoms of Ehlers-Danlos Syndrome with 21-Hydroxylase Deficiency.
    Gao Y; Lu L; Yu B; Mao J; Wang X; Nie M; Wu X
    J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32291442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genes and Pseudogenes: Complexity of the RCCX Locus and Disease.
    Carrozza C; Foca L; De Paolis E; Concolino P
    Front Endocrinol (Lausanne); 2021; 12():709758. PubMed ID: 34394006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation of IVS2 -12A/C>G in combination with 707-714delGAGACTAC in the CYP21 gene is caused by deletion of the C4-CYP21 repeat module with steroid 21-hydroxylase deficiency.
    Lee HH; Chang SF; Tsai FJ; Tsai LP; Lin CY
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2726-9. PubMed ID: 12788880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel deletion alleles carrying CYP21A1P/A2 chimeric genes in Brazilian patients with 21-hydroxylase deficiency.
    Coeli FB; Soardi FC; Bernardi RD; de Araújo M; Paulino LC; Lau IF; Petroli RJ; de Lemos-Marini SH; Baptista MT; Guerra-Júnior G; de-Mello MP
    BMC Med Genet; 2010 Jun; 11():104. PubMed ID: 20587039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural analysis of the chimeric CYP21P/CYP21 gene in steroid 21-hydroxylase deficiency.
    Lee HH; Niu DM; Lin RW; Chan P; Lin CY
    J Hum Genet; 2002; 47(10):517-22. PubMed ID: 12376740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tenascin-X haploinsufficiency associated with Ehlers-Danlos syndrome in patients with congenital adrenal hyperplasia.
    Merke DP; Chen W; Morissette R; Xu Z; Van Ryzin C; Sachdev V; Hannoush H; Shanbhag SM; Acevedo AT; Nishitani M; Arai AE; McDonnell NB
    J Clin Endocrinol Metab; 2013 Feb; 98(2):E379-87. PubMed ID: 23284009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of TaqI digestion may lead to incorrect molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Lee HH; de Wijs IJ; Sistermans EA
    Mol Genet Metab; 2000 Aug; 70(4):322-4. PubMed ID: 10993720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.